Cilag Chemie AG Report issue

For profit Phase 1 Phase 2
Founded: Schauffhausen Switzerland (1933)
Status: Acquired by Johnson and Johnson (1959)

Organization Overview

First Clinical Trial
2014
NCT02391181
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Azad Pharma AG

Active Ingredients

Drugs in Phase 2 Trials (1)

Key: Cilag Chemie AG (0) Acquired (1)

jnj-61178104 (1 trial)

Drugs in Phase 1 Trials (1)

iron dextran (INFeD) (1 trial)

Indications

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 2